Amarin Corporation plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AMRN Nasdaq 2836 www.amarincorp.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amarin Corporation plc

Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Jun 10th, 2025 10:00 am
Best Momentum Stocks to Buy for June 10th - Jun 10th, 2025 8:00 am
Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year? - May 29th, 2025 7:40 am
Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Boosting Their Estimates - May 10th, 2025 6:09 am
Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y - May 8th, 2025 10:07 am
Amarin First Quarter 2025 Earnings: Misses Expectations - May 8th, 2025 4:23 am
Amarin Corp PLC (AMRN) Q1 2025 Earnings Call Highlights: Strategic Global Expansion Amidst ... - May 8th, 2025 1:07 am
Amarin: Q1 Earnings Snapshot - May 7th, 2025 5:32 am
Amarin Reports First Quarter 2025 Financial Results - May 7th, 2025 5:00 am
Standex International Corp (SXI) Q3 2025 Earnings Call Highlights: Record Margins and Strategic ... - May 3rd, 2025 1:02 am
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement - Apr 29th, 2025 2:15 pm
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 - Apr 28th, 2025 2:15 pm
Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change - Apr 9th, 2025 5:30 am
Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors - Apr 7th, 2025 5:30 am
Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist - Mar 31st, 2025 6:00 am
Sector Update: Health Care Stocks Mixed Late Afternoon - Mar 19th, 2025 2:01 pm
New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo - Mar 19th, 2025 5:30 am
AMRN's Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan - Mar 13th, 2025 10:12 am
Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Mar 13th, 2025 1:02 am
Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript - Mar 12th, 2025 10:45 am